UPDATE: Phibro Animal Health (PAHC) Tops Q4 EPS by 2c; Guides FY17 EPS Below Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year
August 29, 2016 4:40 PM EDTTEANECK, N.J., Aug. 29, 2016 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its fourth quarter and fiscal year ended June 30, 2016. It also provided guidance for its fiscal year ending June 30, 2017.
Highlights for the June 2016 quarter (compared to the June 2015 quarter) Net sales of $189 million, an increase of 2%Net income of $15 million, an increase of 46%Diluted EPS of $0.38, an increase of 46%Adjusted EBITDA of $28 million, an increase of 4%Adjusted diluted EPS of $0.40, a decrease of... More


